111 related articles for article (PubMed ID: 5953549)
1. [Studies on the transfer of resistance to tumor growth in tumor-bearing animals].
Obayashi T
Kumamoto Igakkai Zasshi; 1966 Jan; 40(1):49-64. PubMed ID: 5953549
[No Abstract] [Full Text] [Related]
2. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
Bregula U; Slowikowska G; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
[No Abstract] [Full Text] [Related]
3. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
Janik P; Dabrowski M; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
[No Abstract] [Full Text] [Related]
4. [Influence of epsilon-aminocaproic acid on the growth of tumor cells in immunized mice].
Bonmassar E; Celi ML; Melan F; Testorelli C
Arch Ital Patol Clin Tumori; 1968; 11(1):187-94. PubMed ID: 5745501
[No Abstract] [Full Text] [Related]
5. Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages.
Yasuhira K
Acta Tuberc Jpn; 1966 Dec; 16(2):78-84. PubMed ID: 5984181
[No Abstract] [Full Text] [Related]
6. Enhanced tumor proliferation in mice treated with phytohaemagglutinin.
Pappas A; Schwarze G; Wolff C; Scheurlen PG
Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 145(5):449-59. PubMed ID: 4282963
[No Abstract] [Full Text] [Related]
7. [Self-enhancement in allografts of an aspecific ascitic tumor (ATPC+)].
Maltzeff N
Lav Ist Anat Istol Patol Univ Studi Perugia; 1967; 27(2):107-22. PubMed ID: 5606081
[No Abstract] [Full Text] [Related]
8. [On the problem of tumor immunology. II].
Speiser P; Karrer K
Krebsarzt; 1965; 20(5):335-40. PubMed ID: 5857124
[No Abstract] [Full Text] [Related]
9. Studies on the behavior of skin autografts following their in vitro treatment with cancer cells.
Biran S; Ben-Hur N; Robinson E
Isr J Med Sci; 1969; 5(5):1077-8. PubMed ID: 4905243
[No Abstract] [Full Text] [Related]
10. Restoration of allograft immunity in tumor-bearing animals by "immune" RNA.
Rigby PG
J Lab Clin Med; 1968 May; 71(5):775-83. PubMed ID: 4869636
[No Abstract] [Full Text] [Related]
11. Studies on the mechanism of prolonged survival of allografts from tumor-bearing donors.
Robinson E; Golakai VK; Schlesinger M
Cancer Res; 1968 Mar; 28(3):462-4. PubMed ID: 4867924
[No Abstract] [Full Text] [Related]
12. Investigations on mononuclear cells of animals sensitized against homologous normal tissue transplants and tumor transplants.
Warnatz H
Arch Immunol Ther Exp (Warsz); 1966; 14(6):748-52. PubMed ID: 5334579
[No Abstract] [Full Text] [Related]
13. [The effect of Ehrlich tumor on allogenic skin transplantation in mice].
Belokhvostov AS
Vopr Onkol; 1970; 16(11):61-5. PubMed ID: 4929049
[No Abstract] [Full Text] [Related]
14. [Experimentally acquired resistance to tumor transplantation and the rejection of homologous skin transplantation in mice].
Enoki Y
Igaku To Seibutsugaku; 1967 Mar; 74(3):185-6. PubMed ID: 4861830
[No Abstract] [Full Text] [Related]
15. The effect of immune organ transplants on homograft rejection in tumor-bearing mice.
Rigby PG
J Lab Clin Med; 1967 May; 69(5):800-9. PubMed ID: 5337458
[No Abstract] [Full Text] [Related]
16. Comparison of the survival of skin grafts from normal mice and mice with Ehrlich ascites tumor.
Hur NB; Biran S; Robinson E
Transplantation; 1966 Mar; 4(2):205-6. PubMed ID: 5326924
[No Abstract] [Full Text] [Related]
17. [Immunoglobulins from a tumor-bearing body as possible regulators of the growth rate of relapses and metastases of Ehrlich carcinoma].
Donenko FV; Moroz LV
Biull Eksp Biol Med; 1995 Jan; 119(1):62-4. PubMed ID: 7718807
[No Abstract] [Full Text] [Related]
18. [Effects of ionizing radiations on some immunological phenomena in Ehrlich's ascites tumor].
Juliani G; Piccotti F; Isoardi Pons A
Minerva Radiol; 1966; 11(1):74-7. PubMed ID: 5909345
[No Abstract] [Full Text] [Related]
19. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
Dvorák R; Lindner J
Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
[No Abstract] [Full Text] [Related]
20. Rejection of lethal tumors after subcutaneous inoculation: a phenomenon of antigenic expression?
Apffel CA; Peters JH
J Natl Cancer Inst; 1967 Dec; 39(6):1129-39. PubMed ID: 4170428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
